跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tezoxil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tezoxil
Approved
STANDARD
Tezoxil
Khandelwal Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d88c6f849a0007ec
Company
Khandelwal Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
d88c6f849a0007ec
Drug Approval Philippines Name
Tezoxil
Product Name
Tezoxil
Registration Number
DRP-7279-01
Brand Name
Tezoxil
Generic Name
Bortezomib
Dosage Form
Powder for Solution fo Injection (IV/SC)
Dosage Strength
3.5mg
Manufacturer
Khandelwal Laboratories Pvt. Ltd.
Importer
Ambica International Crop.
Distributor
Globo Asiatico Ent. Inc.
Issuance Date
29 March 2022
Expiry Date
28 July 2027
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d88c6f849a0007ec
Type
Standard
Back to Philippines FDA Approvals